Safety of lopinavir/ritonavir for the treatment of HIV-infection

Author： Vogel Martin   Rockstroh Jürgen K  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 403-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Long-term lopinavir/ritonavir effective in HIV infection

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir: towards simplifying therapy in HIV infection

By Kaplan Susan S   Hicks Charles B  

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 293-304

Future Medicine

Access to resources Recommend Favorite

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment

By Barragan Patricia   Podzamczer Daniel  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2363-2375

Informa Healthcare

Access to resources Recommend Favorite

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection

By Kaplan Susan S   Hicks Charles B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1573-1585

Informa Healthcare

Access to resources Recommend Favorite